Exact Mass: 417.3242768

Exact Mass Matches: 417.3242768

Found 32 metabolites which its exact mass value is equals to given mass value 417.3242768, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

   

N-Arachidonoyl Isoleucine

2-(icosa-5,8,11,14-tetraenamido)-3-methylpentanoic acid

C26H43NO3 (417.3242768)


N-arachidonoyl isoleucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Isoleucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Isoleucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Isoleucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Arachidonoyl Leucine

2-(icosa-5,8,11,14-tetraenamido)-4-methylpentanoic acid

C26H43NO3 (417.3242768)


N-arachidonoyl leucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Leucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Leucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Leucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Oleoyldopamine

N-[2-(3,4-Dihydroxyphenyl)ethyl]octadec-9-enimidate

C26H43NO3 (417.3242768)


   

Olvanil

N-[(4-Hydroxy-3-methoxyphenyl)methyl]octadec-9-enimidate

C26H43NO3 (417.3242768)


   

N-[2-(3,4-dihydroxyphenyl)ethyl]-9-octadecenamide

N-[2-(3,4-dihydroxyphenyl)ethyl]-9-octadecenamide

C26H43NO3 (417.3242768)


   

CB-52

N-cyclopropyl-11-(2-hydroxy-5-pentylphenoxy)-undecanamide

C26H43NO3 (417.3242768)


   

CB-86

N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamide

C26H43NO3 (417.3242768)


   
   

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-9-octadecenamide

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-9-octadecenamide

C26H43NO3 (417.3242768)


   

1α,25-dihydroxy-23-azavitamin D3 / 1α,25-dihydroxy-23-azacholecalciferol

1α,25-dihydroxy-23-azavitamin D3 / 1α,25-dihydroxy-23-azacholecalciferol

C26H43NO3 (417.3242768)


   

Olvanil

N-[(4-hydroxy-3-methoxyphenyl)methyl]-9Z-octadecenamide

C26H43NO3 (417.3242768)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

N-arachidonoyl isoleucine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-isoleucine

C26H43NO3 (417.3242768)


   

N-arachidonoyl leucine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-leucine

C26H43NO3 (417.3242768)


   

N-Oleoyl Dopamine

N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-octadecenamide

C26H43NO3 (417.3242768)


   

NA 26:5;O2

N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-octadecenamide

C26H43NO3 (417.3242768)


   

1alpha,25-dihydroxy-23-azavitamin D3 / 1alpha,25-dihydroxy-23-azacholecalciferol

1alpha,25-dihydroxy-23-azavitamin D3 / 1alpha,25-dihydroxy-23-azacholecalciferol

C26H43NO3 (417.3242768)


   

N-Vanillyl-9-octadecenamide

N-Vanillyl-9-octadecenamide

C26H43NO3 (417.3242768)


   

1alpha,25-Dihydroxy-23-azavitamin D3/1alpha,25-dihydroxy-23-azacholecalciferol

1alpha,25-Dihydroxy-23-azavitamin D3/1alpha,25-dihydroxy-23-azacholecalciferol

C26H43NO3 (417.3242768)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

(9E)-N-[2-(3,4-Dihydroxyphenyl)ethyl]octadec-9-enamide

(9E)-N-[2-(3,4-Dihydroxyphenyl)ethyl]octadec-9-enamide

C26H43NO3 (417.3242768)


   

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-3-methylpentanoic acid

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-3-methylpentanoic acid

C26H43NO3 (417.3242768)


   

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-4-methylpentanoic acid

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-4-methylpentanoic acid

C26H43NO3 (417.3242768)


   

Glycoursocholanic acid

Glycoursocholanic acid

C26H43NO3 (417.3242768)


   

(3Z,6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-3,6,9,12,15-pentaenamide

C26H43NO3 (417.3242768)


   

(6Z,9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadeca-6,9,12,15-tetraenamide

C26H43NO3 (417.3242768)


   

(4Z,7Z,10Z,13Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadeca-4,7,10,13-tetraenamide

C26H43NO3 (417.3242768)


   
   

NA-Dopamine 18:1(9Z)

NA-Dopamine 18:1(9Z)

C26H43NO3 (417.3242768)


   

NA-Ile 20:4(5Z,8Z,11Z,14Z)

NA-Ile 20:4(5Z,8Z,11Z,14Z)

C26H43NO3 (417.3242768)


   

NA-Leu 20:4(5Z,8Z,11Z,14Z)

NA-Leu 20:4(5Z,8Z,11Z,14Z)

C26H43NO3 (417.3242768)